Retinoblastoma gene product as a downstream target for a ceramide-dependent pathway of growth arrest

Ghassan S. Dbaibo, Marina Y. Pushkareva, Supriya Jayadev, James K Schwarz, Jonathan M. Horowitz, Lina M. Obeid, Yusuf A. Hannun

Research output: Contribution to journalArticle

197 Citations (Scopus)

Abstract

Ceramide, a lipid mediator, has been most closely associated with antiproliferative activities. In this study, we examine the mechanism by which ceramide induces growth suppression and the role of the retinoblastoma gene product (Rb) in this process. Withdrawal of serum from the serum-dependent MOLT-4 cells resulted in significant dephosphorylation of Rb, correlating with the induction of G0/G1 cell cycle arrest. Serum withdrawal resulted in marked elevation in the levels of endogenous ceramide (3-fold at 24 h and 8-fold at 96 h) with little changes in the endogenous levels of sphingosine. The addition of exogenous C6-ceramide resulted in a concentration- and time-dependent dephosphorylation of Rb. Exogenous ceramide was active at levels comparable to endogenous levels achieved with serum withdrawal. Peak activity of exogenous ceramide (at 6 h) correlated with the uptake of C6-ceramide by MOLT-4 cells. Next, a number of studies were conducted to determine whether Rb plays a role in ceramide-induced growth suppression. (i) C6-Ceramide was poorly active in growth suppression of retinoblastoma cells that lack Rb. (ii) Mink lung epithelial cells in which Rb had been sequestered by overexpression of large tumor antigen were resistant to the action of ceramide compared to cells transfected with large tumor antigen mutated in the Rb-binding pocket, (iii) Overexpression of the E1A adenoviral protein, which binds and sequesters Rb, resulted in protection from growth suppression and cell cycle arrest induced by ceramide. Thus, these studies demonstrate that Rb is a downstream target for ceramide and may function in a growth suppressor pathway resulting in cell cycle arrest.

Original languageEnglish (US)
Pages (from-to)1347-1351
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume92
Issue number5
DOIs
StatePublished - Feb 28 1995

Fingerprint

Retinoblastoma Genes
Ceramides
Growth
Neoplasm Antigens
Cell Cycle Checkpoints
Serum
G1 Phase Cell Cycle Checkpoints
Mink
Sphingosine
Retinoblastoma
Epithelial Cells
Lipids
Lung

ASJC Scopus subject areas

  • General

Cite this

Retinoblastoma gene product as a downstream target for a ceramide-dependent pathway of growth arrest. / Dbaibo, Ghassan S.; Pushkareva, Marina Y.; Jayadev, Supriya; Schwarz, James K; Horowitz, Jonathan M.; Obeid, Lina M.; Hannun, Yusuf A.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 92, No. 5, 28.02.1995, p. 1347-1351.

Research output: Contribution to journalArticle

Dbaibo, Ghassan S. ; Pushkareva, Marina Y. ; Jayadev, Supriya ; Schwarz, James K ; Horowitz, Jonathan M. ; Obeid, Lina M. ; Hannun, Yusuf A. / Retinoblastoma gene product as a downstream target for a ceramide-dependent pathway of growth arrest. In: Proceedings of the National Academy of Sciences of the United States of America. 1995 ; Vol. 92, No. 5. pp. 1347-1351.
@article{69f1aa0f53954c03a0b9952515e9566e,
title = "Retinoblastoma gene product as a downstream target for a ceramide-dependent pathway of growth arrest",
abstract = "Ceramide, a lipid mediator, has been most closely associated with antiproliferative activities. In this study, we examine the mechanism by which ceramide induces growth suppression and the role of the retinoblastoma gene product (Rb) in this process. Withdrawal of serum from the serum-dependent MOLT-4 cells resulted in significant dephosphorylation of Rb, correlating with the induction of G0/G1 cell cycle arrest. Serum withdrawal resulted in marked elevation in the levels of endogenous ceramide (3-fold at 24 h and 8-fold at 96 h) with little changes in the endogenous levels of sphingosine. The addition of exogenous C6-ceramide resulted in a concentration- and time-dependent dephosphorylation of Rb. Exogenous ceramide was active at levels comparable to endogenous levels achieved with serum withdrawal. Peak activity of exogenous ceramide (at 6 h) correlated with the uptake of C6-ceramide by MOLT-4 cells. Next, a number of studies were conducted to determine whether Rb plays a role in ceramide-induced growth suppression. (i) C6-Ceramide was poorly active in growth suppression of retinoblastoma cells that lack Rb. (ii) Mink lung epithelial cells in which Rb had been sequestered by overexpression of large tumor antigen were resistant to the action of ceramide compared to cells transfected with large tumor antigen mutated in the Rb-binding pocket, (iii) Overexpression of the E1A adenoviral protein, which binds and sequesters Rb, resulted in protection from growth suppression and cell cycle arrest induced by ceramide. Thus, these studies demonstrate that Rb is a downstream target for ceramide and may function in a growth suppressor pathway resulting in cell cycle arrest.",
author = "Dbaibo, {Ghassan S.} and Pushkareva, {Marina Y.} and Supriya Jayadev and Schwarz, {James K} and Horowitz, {Jonathan M.} and Obeid, {Lina M.} and Hannun, {Yusuf A.}",
year = "1995",
month = "2",
day = "28",
doi = "10.1073/pnas.92.5.1347",
language = "English (US)",
volume = "92",
pages = "1347--1351",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "5",

}

TY - JOUR

T1 - Retinoblastoma gene product as a downstream target for a ceramide-dependent pathway of growth arrest

AU - Dbaibo, Ghassan S.

AU - Pushkareva, Marina Y.

AU - Jayadev, Supriya

AU - Schwarz, James K

AU - Horowitz, Jonathan M.

AU - Obeid, Lina M.

AU - Hannun, Yusuf A.

PY - 1995/2/28

Y1 - 1995/2/28

N2 - Ceramide, a lipid mediator, has been most closely associated with antiproliferative activities. In this study, we examine the mechanism by which ceramide induces growth suppression and the role of the retinoblastoma gene product (Rb) in this process. Withdrawal of serum from the serum-dependent MOLT-4 cells resulted in significant dephosphorylation of Rb, correlating with the induction of G0/G1 cell cycle arrest. Serum withdrawal resulted in marked elevation in the levels of endogenous ceramide (3-fold at 24 h and 8-fold at 96 h) with little changes in the endogenous levels of sphingosine. The addition of exogenous C6-ceramide resulted in a concentration- and time-dependent dephosphorylation of Rb. Exogenous ceramide was active at levels comparable to endogenous levels achieved with serum withdrawal. Peak activity of exogenous ceramide (at 6 h) correlated with the uptake of C6-ceramide by MOLT-4 cells. Next, a number of studies were conducted to determine whether Rb plays a role in ceramide-induced growth suppression. (i) C6-Ceramide was poorly active in growth suppression of retinoblastoma cells that lack Rb. (ii) Mink lung epithelial cells in which Rb had been sequestered by overexpression of large tumor antigen were resistant to the action of ceramide compared to cells transfected with large tumor antigen mutated in the Rb-binding pocket, (iii) Overexpression of the E1A adenoviral protein, which binds and sequesters Rb, resulted in protection from growth suppression and cell cycle arrest induced by ceramide. Thus, these studies demonstrate that Rb is a downstream target for ceramide and may function in a growth suppressor pathway resulting in cell cycle arrest.

AB - Ceramide, a lipid mediator, has been most closely associated with antiproliferative activities. In this study, we examine the mechanism by which ceramide induces growth suppression and the role of the retinoblastoma gene product (Rb) in this process. Withdrawal of serum from the serum-dependent MOLT-4 cells resulted in significant dephosphorylation of Rb, correlating with the induction of G0/G1 cell cycle arrest. Serum withdrawal resulted in marked elevation in the levels of endogenous ceramide (3-fold at 24 h and 8-fold at 96 h) with little changes in the endogenous levels of sphingosine. The addition of exogenous C6-ceramide resulted in a concentration- and time-dependent dephosphorylation of Rb. Exogenous ceramide was active at levels comparable to endogenous levels achieved with serum withdrawal. Peak activity of exogenous ceramide (at 6 h) correlated with the uptake of C6-ceramide by MOLT-4 cells. Next, a number of studies were conducted to determine whether Rb plays a role in ceramide-induced growth suppression. (i) C6-Ceramide was poorly active in growth suppression of retinoblastoma cells that lack Rb. (ii) Mink lung epithelial cells in which Rb had been sequestered by overexpression of large tumor antigen were resistant to the action of ceramide compared to cells transfected with large tumor antigen mutated in the Rb-binding pocket, (iii) Overexpression of the E1A adenoviral protein, which binds and sequesters Rb, resulted in protection from growth suppression and cell cycle arrest induced by ceramide. Thus, these studies demonstrate that Rb is a downstream target for ceramide and may function in a growth suppressor pathway resulting in cell cycle arrest.

UR - http://www.scopus.com/inward/record.url?scp=0028934811&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028934811&partnerID=8YFLogxK

U2 - 10.1073/pnas.92.5.1347

DO - 10.1073/pnas.92.5.1347

M3 - Article

VL - 92

SP - 1347

EP - 1351

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 5

ER -